Our data show that FK866, a highly specific non-competitive inhibitor of Nampt, reduces expression of H2S-producing enzymes, diminishes production of H2S, and leads to depletion of ATP in cancer cells that recover from damage. The gene discussed is NAMPT; the disease is cancer.